«Testosterone therapy does not
increase aggressive prostate cancer risk.»
Not exact matches
«Genetic association with
aggressive prostate cancer discovered: Study showed a threefold
increase in the risk of
aggressive prostate cancer for men with the genetic mutation..»
Even more troubling, her study found a link between high blood levels of lycopene's chemical cousin, beta - carotene, and an
increased risk of
aggressive prostate cancer — not enough to justify avoiding carrots and other food sources of beta - carotene but an ominous sign that not all food - derived compounds are necessarily benign when taken at higher doses.
In the study, researchers found that, as a group, men prescribed testosterone for longer than a year had no overall
increase in risk of
prostate cancer and, in fact, had their risk of
aggressive disease reduced by 50 percent.
Scientists are reporting a test which can predict which patients are most at risk from
aggressive prostate cancer, and whether they suffer an
increased chance of treatment failure.
A new population - based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five - year period was not associated with an
increased risk of
aggressive prostate cancer.
After following 154 men with low - risk
prostate cancer for 38 months, the investigators found that low levels of free testosterone were significantly linked with an
increased risk of developing more
aggressive disease.
PSMA is overexpressed in
prostate and
increases in its expression in the
aggressive forms of
prostate cancer.
(1) Lower Testosterone Levels (not higher levels) are associated with
increased risk for
aggressive prostate cancer.
Over-inhibition of 5AR, however, has been linked to
increased risk of
aggressive prostate cancer.
The researchers concluded that men with a PSA level above 2 ng / ml at age 60 should be considered at
increased risk of
aggressive prostate cancer and should continue to be screened regularly.